Literature DB >> 10987113

Hepatitis B.

A S Befeler1, A M Di Bisceglie.   

Abstract

The hepatitis B virus is a hepatotropic virus that can produce a variety of clinical syndromes in patients ranging in age from infants to elderly adults. Worldwide, it is among the leading causes of fulminant hepatic failure, cirrhosis, and hepatocellular carcinoma. Recent advances have led to effective antiviral treatments using interferon and nucleoside analogues. Highly effective vaccinations also are used widely and ultimately may lead to eradication of this life-threatening virus.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10987113     DOI: 10.1016/s0891-5520(05)70124-0

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  3 in total

1.  Anti-HBV hairpin ribozyme-mediated cleavage of target RNA in vitro.

Authors:  Yu-Hu Song; Ju-Sheng Lin; Nan-Zhi Liu; Xin-Juan Kong; Na Xie; Nan-Xia Wang; You-Xin Jin; Kuo-Huan Liang
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

2.  Anti-HBV effect of TAT- HBV targeted ribonuclease.

Authors:  Jin Ding; Jun Liu; Cai-Fang Xue; Wei-Dong Gong; Ying-Hui Li; Ya Zhao
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

Review 3.  [Viral infections of the fetus and newborn infant].

Authors:  S Tremolada; S Delbue; P Ferrante
Journal:  Pediatr Med Chir       Date:  2008 Jul-Aug
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.